Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients with Parkinson’s disease-related dementia and Lewy body dementia. Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients with Parkinson’s disease-related dementia and Lewy body dementia.
Daily tablet shows staggering success in slowing or even reversing dementia in new trials
